Micron logo_blue_RGB.jpg
Micron Technology, Inc. Reports Results for the Fourth Quarter and Full Year of Fiscal 2020
September 29, 2020 16:04 ET | Micron Technology, Inc.
DRAM portfolio strengthened with 1z ramp; High-value NAND shipments reach record levels in FY20 BOISE, Idaho, Sept. 29, 2020 (GLOBE NEWSWIRE) -- Micron Technology, Inc. (Nasdaq: MU) today announced...
logo.png
Verisk Elects General Vincent Brooks to Board of Directors
September 29, 2020 16:02 ET | Verisk Analytics, Inc.
Jersey City, NJ, Sept. 29, 2020 (GLOBE NEWSWIRE) -- Verisk (Nasdaq:VRSK), a leading data analytics provider, announces the addition of Gen. Vincent Brooks to its board of directors, effective...
logo1
Galapagos announces first dosing with Toledo compound GLPG3970 in psoriasis trial
September 29, 2020 16:01 ET | Galapagos NV
TOL2/3 inhibitor most advanced compound in novel target class with dual action in inflammatory diseasesPatient trials initiated with GLPG3970 in psoriasis, ulcerative colitis, and rheumatoid...
FCE Logo.jpg
FuelCell Energy Announces Launch of Offering of Common Stock
September 29, 2020 16:01 ET | FuelCell Energy, Inc.
DANBURY, Conn., Sept. 29, 2020 (GLOBE NEWSWIRE) -- FuelCell Energy, Inc. (Nasdaq: FCEL) (“FuelCell Energy” or the “Company”) today announced the launch of an underwritten public offering of...
westell logo.jpg
Westell Stockholders Approve Reverse and Forward Splits
September 29, 2020 16:01 ET | Westell Technologies, Inc.
AURORA, Ill., Sept. 29, 2020 (GLOBE NEWSWIRE) -- Westell Technologies, Inc. (NASDAQ: WSTL), a leading provider of high-performance network infrastructure solutions, announced that at the Annual...
Rubius_Logo.jpg
Rubius Therapeutics to Participate in 7th Annual Jefferies Cell Therapy Summit
September 29, 2020 16:01 ET | Rubius Therapeutics
CAMBRIDGE, Mass., Sept. 29, 2020 (GLOBE NEWSWIRE) -- Rubius Therapeutics, Inc. (Nasdaq:RUBY), a clinical-stage biopharmaceutical company that is genetically engineering red blood cells to create an...
Cytovia.png
Cytovia Therapeutics to present at Jefferies Cell Therapy Virtual Summit, BIO Investor Forum and New York Stem Cell Foundation Conference in October 2020
September 29, 2020 16:00 ET | Cytovia Therapeutics
NEW YORK, Sept. 29, 2020 (GLOBE NEWSWIRE) -- Cytovia Therapeutics, an emerging biopharmaceutical company developing Natural Killer Cell Therapeutics, today announced that it will participate in...
wolf_logo_color_tagline.jpg
GARRETT MOTION INC. CLASS ACTION ALERT: Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action lawsuit has been filed in the United States District Court for the Southern District of New York against Garrett Motion Inc.
September 29, 2020 16:00 ET | Wolf Haldenstein Adler Freeman & Herz LLP
LEAD PLAINTIFF DEADLINE IS NOVEMBER 24, 2020 NEW YORK, Sept. 29, 2020 (GLOBE NEWSWIRE) -- Wolf Haldenstein Adler Freeman & Herz LLP announces that a federal securities class action lawsuit has...
alpha sigma capital.png
Alpha Sigma Capital Invests in Derivatives Crypto-exchange ACDX
September 29, 2020 16:00 ET | Alpha Sigma Capital Fund, LP
Hong Kong, Sept. 29, 2020 (GLOBE NEWSWIRE) -- (via Blockchain Wire) Alpha Sigma Capital (ASC), a pioneering digital asset fund investing in emerging cryptocurrencies and blockchain companies has...
wolf_logo_color_tagline.jpg
GOLAR LNG LIMITED CLASS ACTION ALERT: Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action lawsuit has been filed in the United States District Court for the Southern District of New York against Golar LNG Limited
September 29, 2020 16:00 ET | Wolf Haldenstein Adler Freeman & Herz LLP
LEAD PLAINTIFF DEADLINE IS NOVEMBER 23, 2020 NEW YORK, Sept. 29, 2020 (GLOBE NEWSWIRE) -- Wolf Haldenstein Adler Freeman & Herz LLP announces that a federal securities class action lawsuit...